Pharma industry agrees not to give gifts, sops to doctors

Says actions of few companies have been blemishing the entire industy

The pharmaceutical industry has agreed in principle to enforce a code that will restrict them from offering gifts or other sops to doctors in order to prescribe their medicines, according to Indian Pharmaceutical Alliance (IPA).

"We have expressed our in-principle agreement for the enforcement of the code as actions of a few have been blemishing the image of the entire pharmaceutical industry," IPA Secretary General D G Shah told PTI.

Various industry bodies like Indian Pharmaceutical Alliance (IPA), Organisation of Pharmaceutical Producers of India (OPPI) and Indian Drugs Manufacturers Association (IDMA) attended the meeting.

Shah further said the department has also agreed to fine tune the existing code in order to make it more practical and implementable.

When asked specifically on what the amendments could be, he cited the feasibility of getting signatures from doctors for every medicine sample provided under the existing code as "difficult to implement".

"There are other issues as well which need to be fine tuned. Moreover, it was also discussed as to whether there should be an independent ombudsman for the enforcement of the code or should it be under the government control," he said.

IPA has suggested there should be an independent ombudsman and the Department of Pharmaceuticals has asked other industry bodies to come back with their suggestion within a week, Shah added.

On the timeline for enforcement of the code, he said: "It could take about three months to get the infrastructure ready for the implementation. So towards the end of the year we can expect the code to come into effect".

Comments from Organisation of Pharmaceutical Producers of India (OPPI) and Indian Drugs Manufacturers Association (IDMA) could not be obtained.

Last year, Department of Pharmaceuticals had formulated a voluntary marketing code with an aim to end the alleged practice of pharmaceutical firms giving incentives to doctors to prescribe their medicines.

This is stated to be due to the fact that drug makers cannot advertise their prescription drugs and the same drug is marketed under various brand names by various firms.

Under existing regulations, companies cannot, directly or indirectly, sponsor travel entertainment, hospitality for medical practitioners and their families.

Over 10,000 pharmaceutical companies sell medicines in India and the pharmaceutical market is estimated at nearly Rs 60,000 crore.

image
Business Standard
177 22
Business Standard

Pharma industry agrees not to give gifts, sops to doctors

Says actions of few companies have been blemishing the entire industy

Press Trust of India  |  New Delhi 



The pharmaceutical industry has agreed in principle to enforce a code that will restrict them from offering gifts or other sops to doctors in order to prescribe their medicines, according to Indian Pharmaceutical Alliance (IPA).

"We have expressed our in-principle agreement for the enforcement of the code as actions of a few have been blemishing the image of the entire pharmaceutical industry," IPA Secretary General D G Shah told PTI.

Various industry bodies like Indian Pharmaceutical Alliance (IPA), Organisation of Pharmaceutical Producers of India (OPPI) and Indian Drugs Manufacturers Association (IDMA) attended the meeting.

Shah further said the department has also agreed to fine tune the existing code in order to make it more practical and implementable.



When asked specifically on what the amendments could be, he cited the feasibility of getting signatures from doctors for every medicine sample provided under the existing code as "difficult to implement".

"There are other issues as well which need to be fine tuned. Moreover, it was also discussed as to whether there should be an independent ombudsman for the enforcement of the code or should it be under the government control," he said.

IPA has suggested there should be an independent ombudsman and the Department of Pharmaceuticals has asked other industry bodies to come back with their suggestion within a week, Shah added.

On the timeline for enforcement of the code, he said: "It could take about three months to get the infrastructure ready for the implementation. So towards the end of the year we can expect the code to come into effect".

Comments from Organisation of Pharmaceutical Producers of India (OPPI) and Indian Drugs Manufacturers Association (IDMA) could not be obtained.

Last year, Department of Pharmaceuticals had formulated a voluntary marketing code with an aim to end the alleged practice of pharmaceutical firms giving incentives to doctors to prescribe their medicines.

This is stated to be due to the fact that drug makers cannot advertise their prescription drugs and the same drug is marketed under various brand names by various firms.

Under existing regulations, companies cannot, directly or indirectly, sponsor travel entertainment, hospitality for medical practitioners and their families.

Over 10,000 pharmaceutical companies sell medicines in India and the pharmaceutical market is estimated at nearly Rs 60,000 crore.

RECOMMENDED FOR YOU

Pharma industry agrees not to give gifts, sops to doctors

Says actions of few companies have been blemishing the entire industy

The pharmaceutical industry has agreed in principle to enforce a code that will restrict them from offering gifts or other sops to doctors in order to prescribe their medicines, according to Indian Pharmaceutical Alliance (IPA).

The pharmaceutical industry has agreed in principle to enforce a code that will restrict them from offering gifts or other sops to doctors in order to prescribe their medicines, according to Indian Pharmaceutical Alliance (IPA).

"We have expressed our in-principle agreement for the enforcement of the code as actions of a few have been blemishing the image of the entire pharmaceutical industry," IPA Secretary General D G Shah told PTI.

Various industry bodies like Indian Pharmaceutical Alliance (IPA), Organisation of Pharmaceutical Producers of India (OPPI) and Indian Drugs Manufacturers Association (IDMA) attended the meeting.

Shah further said the department has also agreed to fine tune the existing code in order to make it more practical and implementable.

When asked specifically on what the amendments could be, he cited the feasibility of getting signatures from doctors for every medicine sample provided under the existing code as "difficult to implement".

"There are other issues as well which need to be fine tuned. Moreover, it was also discussed as to whether there should be an independent ombudsman for the enforcement of the code or should it be under the government control," he said.

IPA has suggested there should be an independent ombudsman and the Department of Pharmaceuticals has asked other industry bodies to come back with their suggestion within a week, Shah added.

On the timeline for enforcement of the code, he said: "It could take about three months to get the infrastructure ready for the implementation. So towards the end of the year we can expect the code to come into effect".

Comments from Organisation of Pharmaceutical Producers of India (OPPI) and Indian Drugs Manufacturers Association (IDMA) could not be obtained.

Last year, Department of Pharmaceuticals had formulated a voluntary marketing code with an aim to end the alleged practice of pharmaceutical firms giving incentives to doctors to prescribe their medicines.

This is stated to be due to the fact that drug makers cannot advertise their prescription drugs and the same drug is marketed under various brand names by various firms.

Under existing regulations, companies cannot, directly or indirectly, sponsor travel entertainment, hospitality for medical practitioners and their families.

Over 10,000 pharmaceutical companies sell medicines in India and the pharmaceutical market is estimated at nearly Rs 60,000 crore.

image
Business Standard
177 22
Widgets Magazine

More News

  • Tata Sons reaches for the sky, infuse more funds in Vistara, Air Asia Tata Sons reaches for the sky, infuses more funds in Vistara, AirAsia
  • A farmer casts urea on her mustard field in Allahabad Birla plans to exit low-margins business in India, abroad
Widgets Magazine
Widgets Magazine

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard